RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret Share Price

Equities

RTALB

TRERTAL00018

Pharmaceuticals

Market Closed - Borsa Istanbul 16:09:44 26/04/2024 BST 5-day change 1st Jan Change
12.91 TRY +0.08% Intraday chart for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret +0.23% -9.97%

Financials

Sales 2021 384M 11.83M 944M Sales 2022 86.03M 2.65M 211M Capitalization 1.3B 39.98M 3.19B
Net income 2021 114M 3.51M 280M Net income 2022 281M 8.65M 690M EV / Sales 2021 2.2 x
Net cash position 2021 107M 3.31M 264M Net cash position 2022 79.61M 2.45M 196M EV / Sales 2022 14.2 x
P/E ratio 2021
8.31 x
P/E ratio 2022
4.62 x
Employees 54
Yield 2021 *
-
Yield 2022
-
Free-Float 80.67%
More Fundamentals * Assessed data
Dynamic Chart
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.(IBSE:RTALB) dropped from S&P Global BMI Index CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.(IBSE:RTALB) added to S&P Global BMI Index CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
More news
1 day+0.08%
1 week+0.23%
Current month+5.04%
1 month+4.70%
3 months-14.39%
6 months-3.94%
Current year-9.97%
More quotes
1 week
12.73
Extreme 12.73
13.40
1 month
11.11
Extreme 11.11
13.96
Current year
11.11
Extreme 11.11
17.35
1 year
6.50
Extreme 6.5
21.20
3 years
5.77
Extreme 5.7666
21.20
5 years
0.49
Extreme 0.4899
27.80
10 years
0.49
Extreme 0.4899
27.80
More quotes
Managers TitleAgeSince
Chief Executive Officer - 12/07/21
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman 53 26/09/18
Director/Board Member 55 26/09/18
Chief Executive Officer - 12/07/21
More insiders
Date Price Change Volume
26/04/24 12.91 +0.08% 2,403,458
25/04/24 12.9 +0.39% 2,427,451
24/04/24 12.85 -0.31% 4,732,905
22/04/24 12.89 +0.08% 3,893,623

Delayed Quote Borsa Istanbul, April 26, 2024 at 04:09 pm

More quotes
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is a Turkey-based company engaged in the research, development and production of in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.
More about the company